Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
Open accessAbstract
Endocannabinoids are released 'on-demand' on the basis of physiological need, and can be pharmacologically augmented by inhibiting their catabolic degradation. The endocannabinoid anandamide is degraded by the catabolic enzyme fatty acid amide hydrolase (FAAH). Anandamide is implicated in the mediation of fear behaviors, including fear extinction, suggesting that selectively elevating brain anandamide could modulate plastic changes in fear. Here we first tested this hypothesis with preclinical experiments employing a novel, potent and selective FAAH inhibitor, AM3506 (5-(4-hydroxyphenyl)pentanesulfonyl fluoride). Systemic AM3506 administration before extinction decreased fear during a retrieval test in a mouse model of impaired extinction. AM3506 had no effects on fear in the absence of extinction training, or on various non-fear-related measures. Anandamide levels in the basolateral amygdala were increased by extinction training and augmented by systemic AM3506, whereas application of AM3506 to amygdala slices promoted long-term depression of inhibitory transmission, a form of synaptic plasticity linked to extinction. Further supporting the amygdala as effect-locus, the fear-reducing effects of systemic AM3506 were blocked by intra-amygdala infusion of a CB1 receptor antagonist and were fully recapitulated by intra-amygdala infusion of AM3506. On the basis of these preclinical findings, we hypothesized that variation in the human FAAH gene would predict individual differences in amygdala threat-processing and stress-coping traits. Consistent with this, carriers of a low-expressing FAAH variant (385A allele; rs324420) exhibited quicker habituation of amygdala reactivity to threat, and had lower scores on the personality trait of stress-reactivity. Our findings show that augmenting amygdala anandamide enables extinction-driven reductions in fear in mouse and may promote stress-coping in humans.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
With chronic drug exposure, endocannabinoid neuroadaptations that modulate stress responses may contribute to enhanced stress reactivity in addiction.
“In particular, with chronic drug exposure, neuro-adaptations in the endocannabinoid system, which modulates the response of the brain to stress,85 might contribute to the enhanced stress reactivity in addiction.”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [85]
Inhibition of FAAH could represent a risk variant for stressor-related psychiatric disorders.
“This work was furthered by Gunduz-Cinar et al. (84, 85) who showed that inhibition of fatty acid amide hydrolase (FAAH), the enzyme that catabolizes the endogenous cannabinoid anandamide, enhances extinction learning in rodents and could represent a risk variant for stressor-related psychiatric disorders (84, 85).”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [85]
Inhibition of fatty acid amide hydrolase (FAAH) enhances extinction learning in rodents.
“This work was furthered by Gunduz-Cinar et al. (84, 85) who showed that inhibition of fatty acid amide hydrolase (FAAH), the enzyme that catabolizes the endogenous cannabinoid anandamide, enhances extinction learning in rodents and could represent a risk variant for stressor-related psychiatric disorders (84, 85).”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [85]
Inhibition of FAAH facilitates long-term fear extinction and rescues deficient fear extinction in rodent models by enhancing AEA-CB1 receptor signaling and synaptic plasticity in the BLA.
“Additionally, inhibition of FAAH facilitates long-term fear extinction and rescues deficient fear extinction in rodent models by enhancing AEA–CB1 (cannabinoid type 1) receptor signaling and synaptic plasticity in the BLA.”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [50]
CB1R signaling generated by increased AEA can produce long-term depression of inhibitory transmission in the BLA, a change in synaptic plasticity which can serve to promote excitability.
“By contrast, CB1R signaling generated by increased AEA can also produce long-term depression of inhibitory transmission in the BLA, a change in synaptic plasticity which can serve to promote excitability [50,51].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [50]
AEA released during extinction relieves a tonic inhibitory brake on BLA output neurons necessary for the encoding of extinction memories.
“This suggests a scheme in which AEA released during extinction relieves a tonic inhibitory brake on BLA output neurons [50,51,86] necessary for the encoding of extinction memories [102] (Figure 2).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [50]
Systemic administration of AM3506 prior to extinction training augmented extinction-induced BLA AEA levels and reduced fear on extinction retrieval in a mouse model of impaired extinction.
“More recently, systemic administration of a novel, potent FAAH inhibitor, AM3506 [100], prior to extinction training augmented extinction-induced BLA AEA levels and reduced fear on extinction retrieval in a mouse model of impaired extinction [50].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [50]
The effects of AM3506 were attributed to the BLA by the finding that infusing the drug directly into the BLA promoted extinction, and intra-BLA infusion of SR141716A blocked the pro-extinction effect of systemically delivered AM3506.
“The effects of AM3506 were attributed to the BLA by the finding that infusing the drug directly into the BLA promoted extinction, and the demonstration that intra-BLA infusion of SR141716A blocked the pro-extinction effect of systemically delivered AM3506 [50].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [50]
A CB1R-dependent form of synaptic plasticity in the BLA, long-term depression of inhibitory GABAergic transmission (LTDi), is enhanced by FAAH knockout and by the FAAH inhibitor AM3506 at doses that promote extinction.
“One notable finding is that a CB1R-dependent form of synaptic plasticity in BLA [51,86], long-term depression of inhibitory GABAergic transmission (LTDi), is enhanced by FAAH KO [51] and by the FAAH inhibitor AM3506 at doses that promote extinction [50].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 61 · Cited by 307
Research works printed but not linked: 1
- [37]First M Spitzer R Gibbon M Williams J Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-Patient Edition New York State Psychiatric Institute, Biometrics Research Department New York 1996
- Authors
- Gunduz-Cinar, O., MacPherson, K. P., Cinar, R., Gamble-George, J., Sugden, K., Williams, B., Godlewski, G., Ramikie, T. S., Gorka, A. X., Alapafuja, S. O., Nikas, S. P., Makriyannis, A., Poulton, R., Patel, S., Hariri, A. R., Caspi, A., Moffitt, T. E., Kunos, G., & Holmes, A.
- Affiliations
- National Institutes of Health (US)
- Duke University (US)
- Vanderbilt University Medical Center (US)
- Northeastern University (US)
- University of Otago (NZ)
- Corresponding author
- Holmes, A
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 2012-06-12
- Volume
- 18
- Issue
- 7
- Pages
- 813-823
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC3549323
- OpenAlex
- W2021317290
- Cited by
- 307
- References
- 61
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 16 · 2023: 23 · 2022: 22 · 2021: 33 · 2020: 27 · 2019: 19 · 2018: 19 · 2017: 20 · 2016: 33 · 2015: 30 · 2014: 18 · 2013: 17 · 2012: 5
- FWCI
- 16.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Royal Society
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (ZIAAA000411)
- National Institute on Aging (AG-032282, R01AG032282)
- National Institute of Mental Health (MH-077874, R01MH077874, MH072837, K08MH090412, K01MH072837, MH090412)
- National Institute on Drug Abuse (DA031579, R01DA031579)
- National Institute of General Medical Sciences (R25GM062459)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- anandamide, endocannabinoids, fear extinction, amygdala, FAAH inhibition, threat processing, stress reactivity, stress coping, CB1 receptor, synaptic plasticity, long-term depression, individual differences, habituation
- MeSH terms
- Rimonabant, Fatty Acid Amide Hydrolases, Adaptation, Psychological, Adult, Alkanesulfonates, Amidohydrolases, Amygdala, Animals, Arachidonic Acids, Conditioning, Psychological, Enzyme Inhibitors, Extinction, Psychological, Fear, Female, Habituation, Psychophysiologic, Humans, Male, Microinjections, Middle Aged, Neuronal Plasticity, Personality, Phenols, Piperidines, Pyrazoles, Polymorphism, Single Nucleotide, Mice, Polyunsaturated Alkamides, Genetic Association Studies, Functional Neuroimaging, Cannabinoid Receptor Antagonists, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review